Jean Luc Butel

CIK: 0001260801

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RANI

Rani Therapeutics Holdings, Inc.

Director

TAK

TAKEDA PHARMACEUTICAL CO LTD

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

RANI
Rani Therapeutics Holdings, Inc.
May 28, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
123.6K shares-
RANI
Rani Therapeutics Holdings, Inc.
May 28, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
50K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
101.3K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Award(A)
Stock Option (Right to Buy)
Direct
101.3K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
18.9K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Award(A)
Stock Option (Right to Buy)
Direct
18.9K shares-

		Type	Shares	Price		Ownership
May 28, 2026	RANI Rani Therapeutics Holdings, Inc.	Award(A) Director Stock Option (Right to Buy)	123,600	-	-	Direct
May 28, 2025	RANI Rani Therapeutics Holdings, Inc.	Award(A) Director Stock Option (Right to Buy)	50,000	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Disposition(D) Stock Option (Right to Buy)	101,276	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	101,276	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Disposition(D) Stock Option (Right to Buy)	18,875	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	18,875	-	-	Direct

1-6 of 6 transactions

About BUTEL JEAN LUC

BUTEL JEAN LUC (SEC CIK 0001260801) files insider reports with the SEC as Director of Rani Therapeutics Holdings, Inc. (RANI) and Director of TAKEDA PHARMACEUTICAL CO LTD (TAK).

Signal8 holds 4 ownership filings by BUTEL JEAN LUC (1 Form 3, 3 Form 4), filed between Dec 17, 2024 and Jun 1, 2026. Those filings report 6 transactions, from Dec 16, 2024 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BUTEL JEAN LUC's filings is in SAN JOSE, CA.

Recent filings by BUTEL JEAN LUC

May 28, 2026: Grant or award of RANI derivative securities (Form 4, code A).
May 28, 2025: Grant or award of RANI derivative securities (Form 4, code A).
Dec 16, 2024: Disposition to issuer transaction of RANI derivative securities (Form 4, code D).
Dec 16, 2024: Grant or award of RANI derivative securities (Form 4, code A).
Dec 16, 2024: Disposition to issuer transaction of RANI derivative securities (Form 4, code D).

Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)

Imran Talat, Chief Executive Officer
Javadi Alireza, Chief Technical Officer
Gilson Michelle, Director
IMRAN MIR A, Director
Maestas Nicholas, Chief Financial Officer
McKinley Kate, Chief Business Officer

How to read Form 4 transaction codes